Get the tools used by (smart)2 investors.
SP500 -0.2%DOW -0.9%FTSE 100 -4.3%NIKKEI 4.3%OIL -2.8%GOLD -2.1%
Sign In
WatchlistsIdeasScreenerData ExplorerChartsSaved Work

AFFO / Share Forecast Median Consensus for Phathom Pharmaceuticals Inc

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

PHAT: Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes treatments for gastrointestinal diseases. The company develops its products based on vonozopran, an investigatio...

4.87 USD
Price
– USD
Fair Value
–
Upside
4.07 - 19.71
52-week range
Create ChartCreate ModelAdd To Watchlist

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Phathom Pharmaceuticals Inc's AFFO / Share Forecast Median Consensus:

Dec 2026Dec 2028Dec 2030Dec 2032Dec 20340
Performance Summary

    How does Phathom Pharma's AFFO / Share Forecast Median Consensus benchmark against competitors?

    Hide this widget

    We've identified the following companies as similar to Phathom Pharmaceuticals Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

    Phathom Pharma AFFO / Share Forecast Median Consensus Benchmarks
    NameTickerAFFO / Share Forecast Median Consensus
    Phathom Pharmaceuticals IncNASDAQGS:PHAT-
    HealthcareSECTOR:HLTH.US0
    Cumberland Pharmaceuticals IncNASDAQGS:CPIX-
    Redhill Biopharma LtdNASDAQCM:RDHL-
    4Front Ventures CorpOTCPK:FFNT.F-
    Harmony Biosciences HoldingsNASDAQGM:HRMY-
    Evolus IncNASDAQGM:EOLS-
    Tarsus Pharmaceuticals IncNASDAQGS:TARS-
    Corcept Therapeutics IncorporatedNASDAQCM:CORT-
    Vyne Therapeutics IncNASDAQCM:VYNE-
    Evoke Pharma IncNASDAQCM:EVOK-
    Esperion Therapeutics IncNASDAQGM:ESPR-

    Metric Usage: AFFO / Share Forecast Median Consensus

    Hide this widget
    affo_share_proj_median_raw
    Slug
    number
    Datatype
    text
    Format
    current
    Default Period
    FY, Q
    Periods Supported
    Free
    Plan

    To view the full list of supported financial metrics please see Complete Metrics Listing.

    Similar Metrics

    Hide this widget

    Metrics similar to AFFO / Share Forecast Median Consensus in the forecast category include:

    View Full List

    Search for metric or datapoint

    AFFO / Share Forecast Median Consensus

    The median AFFO / share Forecast submitted by any analyst for the company.

    Definition of AFFO / Share Forecast Median Consensus

    Hide this widget
    The median AFFO / share Forecast submitted by any analyst for the company.

    Sector Benchmark Analysis

    Sector
    Industry Group
    Industry
    Hide this widget
    0.910.991.071.22011

    The chart above depicts the distribution of affo / share forecast median consensus for companies operating in the Healthcare sector in the Developed economic region. Over 0 companies were considered in this analysis, and 3 had meaningful values. The average affo / share forecast median consensus of companies in the sector is 0.97 with a standard deviation of 0.12.

    Phathom Pharmaceuticals Inc's AFFO / Share Forecast Median Consensus of - is significantly outside the interquartile range and is excluded from the distribution. The following table provides additional summary stats:

    AFFO / Share Forecast Median Consensus In The Healthcare Sector
    Economic Risk RegionDeveloped
    Total Constituents3
    Included Constituents3
    Min0.82
    Max1.12
    Median0.98
    Mean0.97
    Standard Deviation0.12

    You can find companies with similar affo / share forecast median consensus using this stock screener.

    All rights reserved. Terms Of Use